| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.8M | -10.1% |
| Cost of Revenue | $10.4M | -3.4% |
| Gross Profit | $1.5M | -39.5% |
| R&D Expense | $12.7M | +8.6% |
| SG&A Expense | $21.0M | -6.5% |
| Operating Income | -$42.2M | -5.6% |
| Pre-tax Income | -$40.8M | -1.0% |
| Net Income | -$40.8M | -1.0% |
| EPS (Basic) | -$0.64 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $72.6M | -39.6% |
| Accounts Receivable | $3.6M | +58.7% |
| Inventory | $11.3M | -7.3% |
| Current Assets | $91.2M | -33.5% |
| Total Assets | $132.3M | -10.9% |
| Current Liabilities | $15.3M | +267.6% |
| Total Liabilities | $15.6M | +228.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$24.5M | +9.1% |
| Capital Expenditures | $1.7M | -54.8% |
| Investing Cash Flow | -$21.2M | -336.3% |
| Financing Cash Flow | -$1.9M | -101.7% |
| Free Cash Flow | -$26.2M | +14.8% |
| +3.0% |
| EPS (Diluted) | -$0.64 | -23.1% |
| Stockholders' Equity |
| $116.7M |
| -18.8% |